Groww IPO Day 1: Check Subscription Status, Key Highlights, and More

04 November 2025
1 min read
Groww IPO Day 1: Check Subscription Status, Key Highlights, and More
whatsapp
facebook
twitter
linkedin
telegram
copyToClipboard

Groww, India’s No. 1 stockbroker, has launched its ₹6,632.3 crore Initial Public Offering (IPO) for public subscription today, November 4, 2025.  

Ahead of the IPO opening, the company has raised ₹2985 crore from anchor investors on November 3, 2025. 

Groww IPO: Issue Details

Groww IPO is a book-building issue of ₹6,632.3 crore, consisting of a fresh issue of ₹1,060 crore and an offer for sale of ₹5,572.30 crore.

The price band is set between ₹95 and ₹100 per share. The basis of allotment will be finalised by November 10, 2025, and the tentative listing date on BSE and NSE is November 12, 2025. 

Groww IPO Day 1 Subscription Status

[4-November-2025 12:48:00 hrs]

Investor Category

Subscription (Times)

Qualified Institutional Buyers (QIBs)

0.00

Non-Institutional Investors

0.27

Retail Individual Investors (RIIs)

1.16

Total

0.29

Utilisation of IPO Proceeds

The net proceeds from the fresh will be used towards the following objectives:

  • Performance marketing activities
  • To fund expenditure towards cloud infrastructure and inorganic growth through unidentified acquisitions
  • Brand building 
  • Invest in material subsidiaries:
    • Groww Creditserv Technology Private Limited and 
    • Groww Invest Tech Private Limited, to augment its capital base and fund the margin trading facility (“MTF”) business, respectively. 
  • General corporate purposes 

Groww Business Overview

Groww is a D2C (direct-to-customer) digital investment platform. With the Groww app, users can invest in mutual funds, IPOs, bonds, exchange-traded funds (ETFs), and trade in equities and commodities as well. 

Groww is India’s largest and fastest-growing investment platform by active users on NSE as of June 30, 2025. 

 Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.

To read the RA disclaimer, please click here

To read the Groww IPO disclaimer, please click here

Do you like this edition?